Prospective Evaluation of Imaging Response Biomarkers During [177Lu]Lu-PSMA in Metastatic Castration-resistant Prostate Cancer

Description:

Given that data regarding SPECT/CT-based treatment response monitoring during PSMA theranostics are limited, this study aims to prospectively investigate the role of LuPSMA-SPECT/CT imaging for response evaluation during treatment with [177Lu]Lu-PSMA in mCRPC patients.

Sponsor:

University Hospital, Grenoble

[177Lu]Lu-PSMA

Isotope(s):
Target(s):
  • PSMA
XCancer

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468